| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/29/2013 | WO2013126013A1 New method for rapid detection of hepatocyte growth factor in biological fluids |
| 08/29/2013 | WO2013125879A1 Antibody to d-alanine-d-alanine ligase and detection of antibiotic-resistant bacteria using same |
| 08/29/2013 | WO2013125855A1 Novel method for detecting antigen, and apparatus using same |
| 08/29/2013 | WO2013124888A1 3d shape measurement apparatus |
| 08/29/2013 | WO2013124740A2 BRCA DEFICIENCY PROTEIN AND mRNA SIGNATURES USEFUL IN IDENTIFICATION OF PATIENTS WITH BRCA-DEFICIENT TUMORS AND PREDICTING BENEFIT OF ANTI-CANCER THERAPY IN CANCER PATIENTS |
| 08/29/2013 | WO2013124738A2 Methods and biomarkers for detection and prognosis of cervical cancer |
| 08/29/2013 | WO2013124722A1 Calibration of measuring instruments |
| 08/29/2013 | WO2013124675A1 Marker for preterm labour |
| 08/29/2013 | WO2013124672A1 Method of electochemical detection |
| 08/29/2013 | WO2013124668A1 Use of igbpma for binding iga |
| 08/29/2013 | WO2013124630A1 Correction method for estimating free light chain production |
| 08/29/2013 | WO2013124620A1 Method of making a hydrogel |
| 08/29/2013 | WO2013124482A2 Identification of modulators of binding properties of antibodies reactive with a member of the insulin receptor family |
| 08/29/2013 | WO2013124478A1 Symmetric dimethylarginine (sdma) modifies high density lipoprotein (hdl) to induce endothelial dysfunction |
| 08/29/2013 | WO2013124474A2 Chromatographic isolation of cells and other complex biological materials |
| 08/29/2013 | WO2013124462A1 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
| 08/29/2013 | WO2013124406A1 New dual biomarker of neurodegeneration and of neuroregeneration |
| 08/29/2013 | WO2013124325A1 Methods and kits for detection of active malignancy |
| 08/29/2013 | WO2013124307A1 Device for parallelization and performance increase in microarray-immunoassays with solid, non-porous capture-zone |
| 08/29/2013 | WO2013124229A1 Hbv immunocomplexes for response prediction and therapy monitoring of chronic hbv patients |
| 08/29/2013 | WO2013124073A1 Method for the determination of renal function |
| 08/29/2013 | WO2013124072A1 Immunoassay for the detection of c-terminal fragments of agrin containing the 22kda c-terminal fragment (caf) of agrin |
| 08/29/2013 | WO2013123559A1 Rna tagging method |
| 08/29/2013 | WO2013103984A3 Use of galectin-3 for risk assessment and detection of preeclampsia and related conditions |
| 08/29/2013 | WO2013095091A3 Rsv g protein specific antibodies |
| 08/29/2013 | WO2013092952A3 Method for selectively quantifying a-beta aggregates |
| 08/29/2013 | WO2013090857A8 Identification of two novel biomarkers for niemann-pick disease type c |
| 08/29/2013 | WO2013084002A3 Method for detecting nucleosome adducts |
| 08/29/2013 | WO2013079567A3 Nt-proanp and nt-probnp for the diagnosis of stroke |
| 08/29/2013 | WO2013079534A3 Operation of a gas-concentration-monitoring system |
| 08/29/2013 | WO2013077886A3 Protease degradable polypeptides and uses thereof |
| 08/29/2013 | WO2013036101A9 Rubber allergenic proteins and immunoassay derived thereof |
| 08/29/2013 | WO2012121392A8 Azoline compound and azole compound library and method for producing same |
| 08/29/2013 | WO2012099884A8 Methods for amplification and detection of prions |
| 08/29/2013 | US20130226522 Rubber product elastic response performance prediction method, design method, and elastic response performance prediction apparatus |
| 08/29/2013 | US20130226347 Monitoring and control of soil conditions |
| 08/29/2013 | US20130225883 Methods for making and distributing batches of butane-enriched gasoline |
| 08/29/2013 | US20130225668 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 08/29/2013 | US20130225656 ANALYZING SEMAPHORIN7A (Sema7A) LEVELS FOR ASSESSING CANCER METASTATIC POTENTIAL AND METHODS OF TREATMENT |
| 08/29/2013 | US20130225547 Proteasome inhibitors and uses thereof |
| 08/29/2013 | US20130225543 Specific regulation of cytokine levels by hdac6 inhibitors |
| 08/29/2013 | US20130225541 Elevated PSMA Identifies Lethal Prostate Cancers |
| 08/29/2013 | US20130225449 Lateral flow assays using two dimensional features |
| 08/29/2013 | US20130225448 Lateral flow assays using two dimensional features |
| 08/29/2013 | US20130225442 Lung Cancer Tests |
| 08/29/2013 | US20130225439 Methods for improving inflammatory bowel disease diagnosis |
| 08/29/2013 | US20130225438 Solution microarrays and uses thereof |
| 08/29/2013 | US20130225437 Biomarkers of cancer |
| 08/29/2013 | US20130225434 Compositions comprising engineered phosphothreonine affinity reagents, methods of making, and methods of use |
| 08/29/2013 | US20130225433 Prostate cancer markers and uses thereof |
| 08/29/2013 | US20130225430 Methods and compositions for treatment of tox-3 and tff-1 mediated cancer pathogenesis |
| 08/29/2013 | US20130225428 Liver disease markers |
| 08/29/2013 | US20130225427 Method for prediction of response to immune mediated disease therapeutics |
| 08/29/2013 | US20130225425 Modulation of NR2F6 and methods and uses thereof |
| 08/29/2013 | US20130225423 Method for enrichment and isolation of endogenous transcription factor and complexes thereof and corresponding tandem arrays of concatenated transcription factor response elements |
| 08/29/2013 | US20130225403 Compositions for seed treatment |
| 08/29/2013 | US20130224884 Device and method for immunoassays |
| 08/29/2013 | US20130224883 Method for recognizing interferences in in vitro diagnostic assays |
| 08/29/2013 | US20130224880 Reagents and methods for detecting protein crotonylation |
| 08/29/2013 | US20130224878 Biochip well, sealed well assembly, cartridge therefor, and apparatus and methods for opening sealed wells |
| 08/29/2013 | US20130224870 Fluorescence labeling reagents and uses thereof |
| 08/29/2013 | US20130224869 Imaging system and associated method for detection of protein contamination |
| 08/29/2013 | US20130224848 Device and Method for Detection and Quantification of Immunological Proteins, Pathogenic and Microbial Agents and Cells |
| 08/29/2013 | US20130224843 Efficient haploid cell sorting flow cytometer systems |
| 08/29/2013 | US20130224790 Chalcone Structure Fluorescence Dye For Embryonic Stem Cell Probe |
| 08/29/2013 | US20130224789 Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same |
| 08/29/2013 | US20130224787 Flow cytometer method and apparatus |
| 08/29/2013 | US20130224786 Flow cytometer apparatus and method |
| 08/29/2013 | US20130224784 Method for assessing the efficacy of a tr1 cell therapy in a subject |
| 08/29/2013 | US20130224783 Method for detection of liposoluble vitamins |
| 08/29/2013 | US20130224778 Methods for Determination of Ethanol Consumption |
| 08/29/2013 | US20130224777 Screening method for finding samples having antiphospholipid antibodies |
| 08/29/2013 | US20130224776 PCan065 Antibody Compositions and Methods of Use |
| 08/29/2013 | US20130224775 Apparatus and Methods for Analyte Measurement Immunoassay |
| 08/29/2013 | US20130224774 Methods and materials for amplification of a signal in an immunoassay |
| 08/29/2013 | US20130224773 Method for Rapid Growth, Detection and Identification of Live Microorganisms Immobilized on Permeable Membranes by Antibodies |
| 08/29/2013 | US20130224772 Method for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells |
| 08/29/2013 | US20130224771 Anti-mullerian hormone detection in whole blood |
| 08/29/2013 | US20130224770 Antibody Diluent Buffer |
| 08/29/2013 | US20130224769 Methods of using chemokine panec-1 antibodies |
| 08/29/2013 | US20130224768 Immunochromatographic assay method and apparatus |
| 08/29/2013 | US20130224767 Immunochromatographic assay method and apparatus |
| 08/29/2013 | US20130224766 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 08/29/2013 | US20130224761 Non covalent molecular structure, comprising a porphyrin based glycoconjugate, device comprising the same and its use for detection of lectin |
| 08/29/2013 | US20130224760 Zinc-Responsive Peptides, and Methods of Use Thereof |
| 08/29/2013 | US20130224756 Optogenetic probes for measuring membrane potential |
| 08/29/2013 | US20130224754 Method for the selection of compounds useful for the treatment of psychiatric and neurodegenerative diseases |
| 08/29/2013 | US20130224752 Method for early determination of recurrence after therapy for prostate cancer |
| 08/29/2013 | US20130224748 Methods and compositions for detecting endometrial or ovarian cancer |
| 08/29/2013 | US20130224747 Pathogenecity Islands of Pseudomonas Aeruginosa |
| 08/29/2013 | US20130224737 Method For Determining The Production Of Reactive Oxygen Species In A Cellular Population |
| 08/29/2013 | US20130224734 Sperm processing methods |
| 08/29/2013 | US20130224733 Method and apparatus for sorting particles |
| 08/29/2013 | US20130224732 Method for amplifying variation of frequency of signal in piezoelectrical biosensor |
| 08/29/2013 | US20130224727 Systems and methods for sorting particles |
| 08/29/2013 | US20130224726 Method and apparatus for calibrating a flow cytometer |
| 08/29/2013 | US20130224725 Methods for processing sperm cells |
| 08/29/2013 | US20130224313 Cancer therapy method |
| 08/29/2013 | US20130224312 Methods and materials for assessing responsiveness to parp inhibitors and platinating agents |
| 08/29/2013 | US20130224311 Methods and compositions for the treatment of cancer |